Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose phase 1 pharmacokinetic study of bedtime JZP-324 in healthy volunteers
NL-OMON50156Phase 1Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of JZP324 in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Pharmacokinetics of JZP-324 Formulation B. Started Jul 2020; status: completed.
02
Drugs
JZP324
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NL-OMON50156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50156.